Forkhead family transcription factors are critical regulators of cell cycle progression and apoptosis in hematopoietic cells. Here, we show that FOXO3a (also known as FKHRL1) is a new substrate of caspase-3-like proteases during apoptosis in T lymphocytes. FOXO3a was cleaved in vivo by caspases in leukemic Jurkat cells following engagement of Fas (CD95) receptor, staurosporine, and etoposide treatment, but not following engagement of CD99, a caspase-independent cell death inducer. Caspasemediated cleavage of FOXO3a was also observed in CD4 þ peripheral T cells subjected to activation-induced cell death. The expression of the death adapter FADD and caspase-8 was required for Fas-induced FOXO3a cleavage, but activation of survival pathways by overexpression of FLICE-inhibitory protein or phorbol myristate acetate treatment prevented it. FOXO3a was cleaved in vitro by caspase-3-like proteases at the consensus sequence DELD 304 A, releasing the N-terminal DNAbinding domain of FOXO3a from its C-terminal transactivating domain. Whereas full-length FOXO3a enhanced Forkhead response element-dependent transcription and apoptosis in Jurkat cells, both fragments were inactive to promote gene activation and cell death. In contrast, a caspase-resistant FOXO3a mutant exhibited enhanced transcriptional and proapoptotic activities. Together, these results indicate that the proteolytic cleavage of FOXO3a by caspases may represent a novel regulatory mechanism of FOXO3a activity during death receptors signaling.
Introduction
Apoptosis, or programmed cell death, is a fundamental process essential to the normal development and homeostasis of multicellular organisms. The activation by a variety of stimuli of a family of aspartate-specific cysteine proteases (caspases) represents a crucial step in the induction of apoptosis. Cells undergoing apoptosis show characteristic morphological changes, including membrane blebbing, chromatin condensation, and nuclear DNA fragmentation (Nagata, 1997) . These changes are largely due to a caspase-dependent proteolysis of a limited number of substrates, such as structural and cytoskeletal proteins, components of the cell cycle machinery, and proteins involved in genomic stability such as poly(ADP-ribose) polymerase (PARP). Thus, it is clearly a major issue to identify the substrates for caspases in order to understand the molecular events occurring during cell death.
In the immune system, a form of death called activation-induced cell death, or AICD, plays a critical role for the maintenance of lymphocyte homeostasis and immune surveillance. This process limits overexpansion of immune responses by eliminating unwanted proliferating peripheral lymphocytes and autoreactive T cells (Baumann et al., 2002) , and dysregulation in this process has been associated with autoimmune diseases and cancers. AICD in mature T cells proceeds via the activation of the T-cell receptor (TCR) and culminates in expression of Fas and FasL to trigger cell death . The expression of Fas and FasL is critical to AICD, since activated T cells from lpr and gld mice, which express mutated forms of these receptors, are defective in this process (Watanabe-Fukunaga et al., 1992; Takahashi et al., 1994; Alderson et al., 1995) . Engagement of Fas by its ligand induces receptor trimerization, leading to the recruitment of the adaptor FADD (Chinnaiyan et al., 1995) and the cystein protease caspase-8 (FLICE) (Muzio et al., 1996) to the death receptor via death domain and death effector domain interactions. This allows the formation of the death-inducing signaling complex (DISC) (Kischkel et al., 1995) , required for activation of the effector caspases and execution of the apoptotic program.
Members of the Forkhead family, FOXO4 (AFX), FOXO1a (FKHR), and FOXO3a (FKHRL1) are transcription factors playing a critical role in the regulation of apoptosis and cell cycle progression in a wide variety of cells (Brunet et al., 1999; Kashii et al., 2000; Tanaka et al., 2001; Tran et al., 2002) . These proteins, which are the mammalian counterparts of DAF-16 in C. elegans, are substrates for the serine/ threonine kinase Akt (Brunet et al., 1999 (Brunet et al., , 2001 Tang et al., 1999) . Akt is regulated by the activation of phosphatidylinositol 3-kinase (PI3 K) mediated by various stimuli and survival signals provided by the binding of growth factors to their receptors. In the absence of survival signals and PI3 K activity, dephosphorylated FOXO3a is unable to bind the scaffolding protein 14-3-3, and translocates into the nucleus where it can activate the transcription of target genes involved in the induction of apoptosis. FasL and Bim are so far the best-characterized candidate genes to mediate FOXO3a-dependent apoptosis (Brunet et al., 1999; Dijkers et al., 2000a, b) . FOXO3a also activates other genes implicated in the regulation of the cell cycle, such as the cell cycle inhibitor p27 kip1 (Dijkers et al., 2000b; Nakamura et al., 2000) , which may also participate in FOXO3a-induced apoptosis (Lissy et al., 1998; Li et al., 2000) . Although FOXO3a is largely considered as a critical proapoptotic factor in hematopoietic cells, its fate during lymphocyte apoptosis is unknown. Furthermore, it is not known whether phosphorylation of FOXO3a is the only mechanism regulating its activity.
Here, we show that FOXO3a is cleaved by caspase-3-like proteases in vitro, and in vivo in CD4 þ peripheral T cells subjected to AICD and in leukemic Jurkat cells stimulated by anti-Fas antibody. This cleavage separates the N-terminal DNA-binding domain (DBD) of FOXO3a from its C-terminal transactivating domain. Whereas fragments were inactive to promote gene activation and cell death, a caspase-resistant FOXO3a mutant exhibited enhanced transcriptional and proapoptotic activities. Our results suggest that FOXO3a activity during death receptors signaling and apoptosis can be regulated by caspase-mediated proteolysis.
Results

Fas-induced cleavage of FOXO3a is caspase-3-dependent in vivo
FOXO3a is a proapoptotic protein in hematopoietic cells. Fas engagement culminates in the caspasemediated cleavage of a restricted panel of proteins, including transcription factors. Scanning the protein sequence of FOXO3a, we identified a caspase-3 consensus cleavage site (DELD 304 ). A similar motif was conserved in the two others members of the FOXO family, FOXO1a, and FOXO4 ( Figure 1a ). This prompted us to examine the fate of FOXO3a following Fas-induced apoptosis. Jurkat cells were stimulated with anti-Fas CH11 mAb that mimics the apoptogenic effect of FasL. Interestingly, a 40 kDa phosphorylated band was detected with antibodies that recognizes the phosphorylated threonine 32 present in the N-terminus of FOXO3a, after 1 h of CH11 treatment. The phosphorylation of this 40 kDa fragment then slowly disappeared after 4-6 h of CH11 treatment (Figure 1b) . The time course of FOXO3a cleavage was found parallel to that of procaspase-3 and Akt used here as positive controls, and the dephosphorylation of the 40 kDa fragment was consistent with the cleavage of Akt. Moreover, the measurement of caspase-3 activity in Fastreated cells from 1 to 6 h ( Figure 1c ) correlated with the appearance of the 40 kDa cleavage product of FOXO3a. Actin expression remained stable all along the kinetic of incubation with CH11, ruling out the possibility of a decrease in cell number ( Figure 1b) . As a control, the number of annexin V-positive cells increased from 2 h of Fas stimulation, rising 80% after 6 h ( Figure 1d ). To rule out any potential degradation of this fragment instead of a dephosphorylation, Jurkat cells were transfected with HA-FOXO3a and stimulated with CH11 for 4 h. A 40 kDa fragment was detected with antibodies against FOXO3a protein when FOXO3a was overexpressed (Figure 1e ). The endogenous fragment could not be well detected with antibodies against FOXO3a, maybe due to a weak efficiency of the antibodies. However, the cleavage of FOXO3a was confirmed by the disappearance of full-length FOXO3a by immunoblotting with antibodies against FOXO3a (Figure 1b , e). Apoptosis of Jurkat cells induced by etoposide, staurosporine, was also associated with FOXO3a cleavage (Figure 1f ). In contrast, CD99-induced apoptosis described as a caspase-independent process (Pettersen et al., 2001) did not promote FOXO3a cleavage (Figure 1f ). These results show that FOXO3a is cleaved in vivo following Fas engagement, through a process involving caspase-like activities.
To determine whether FOXO3a was actually cleaved by caspases, Jurkat cells were preincubated with various caspase inhibitors and then stimulated with CH11. Fasmediated cleavage of FOXO3a and procaspase-3 were abrogated in the presence of acetyl (Ac)-DEVD-CHO, an inhibitor of caspase-3, and z-VAD-Fmk, a broadspectrum caspase inhibitor (Figure 2a) . Similarly, the Fas-mediated appearance of the 40 kDa Nt fragment was abrogated by both Ac-DEVD-CHO, and Z-VADFmk (Figure 2b ). In contrast, Ac-YVAD-CHO (caspase-1/ICE inhibitor) had no effect on Fas-induced FOXO3a cleavage. Fas-induced apoptosis was confirmed by annexin V binding in more than 80% of cells and was reversed by Z-VAD-Fmk and Ac-DEVD-CHO treatment (2%) (Figure 2c ). These results show that during Fas-mediated apoptosis, FOXO3a is cleaved by caspase-3-like proteases.
Cleavage of FOXO3a during AICD
AICD is a critical physiological process that requires Fas engagement to occur. To investigate the role of FOXO3a during AICD, primed CD4 þ human T cells received a second challenge of stimulation with both anti-CD3 monoclonal antibody (mAb) and interleukin-2 absence(IL-2) in the presence or absence of the pancaspase inhibitor Z-VAD-Fmk. The combination of anti-CD3 plus IL-2 induced the apparition of a phosphorylated FOXO3a fragment at 40 kDa, similar to that observed during Fas-induced apoptosis. Cleavage was abolished by Z-VAD-Fmk, as detected by immunoblotting with antiphosphoT32 antibodies (Figure 3a) . 
Cleavage of FOXO3a requires FADD and caspase-8
The recruitment of FADD and procaspase-8 (FLICE) to the Fas receptor (i.e. the DISC assembly) is a critical step for initiating Fas-induced apoptosis (Juo et al., 1998 . To investigate the role of DISC assembly during FOXO3a cleavage, wild-type ( Figure 4d ). Finally, we examined a potential protective effect of phorbol myristate acetate (PMA) on Fas-induced FOXO3a cleavage. PMA is an antiapoptotic compound, which can prevent DISC assembly and activate survival pathways (Bertolotto et al., 2000; Herrant et al., 2002) . Jurkat cells, whether preincubated or not with PMA, were then stimulated for 6 h with CH11. Cleavage of FOXO3a and caspase-3 was prevented by PMA treatment ( Figure 4e ). As a control, expression of actin was constant. Moreover, PMA was also found to inhibit apoptosis as judged by annexin V binding ( Figure 4f ). All together, our results show that Fas-mediated FOXO3a cleavage requires components of Fas signaling pathway such as the adaptor FADD and the caspase-8 and can be reversed by activation of survival pathways.
Cleavage of FOXO3a occurs at the consensus caspase-3 site DELD 304 in vitro
We next examined whether FOXO3a could be a substrate for caspases in vitro. FOXO3a was transcribed and translated in vitro in the presence of [ 35 S]methionine and incubated with recombinant caspase-3, -6, and -7, or cellular lysates from staurosporine-stimulated Jurkat cells in the presence or absence of Ac-DEVD-CHO. FOXO3a was cleaved in vitro either by caspase-3, -6, -7 or cell extracts, as shown by the disappearance of fulllength FOXO3a band and the generation of two fragments at 40 kDa (Nt fragment) and 45 kDa (Ct fragment) (Figure 5a,b) . FOXO3a cleavage was abrogated in the presence of Ac-DEVD-CHO. Interestingly, caspase-3 and -7 generated similar fragments, while cleavage by caspase-6 seemed to be different. Next, we replaced aspartate (D) by alanine (A) in the DELD 304 consensus site (Figure 5b ). In vitro transcribed and translated WT or D304A FOXO3a were incubated with cellular lysates from staurosporine-stimulated Jurkat cells. In contrast to WT FOXO3a, D304A FOXO3a was not cleaved in vitro (Figure 5c ). FOXO3a is regulated by (Brunet et al., 1999) . We therefore examined whether mutations of these residues to alanine (triple mutant (TM) FOXO3a) could affect FOXO3a cleavage in vitro. The constitutively active FOXO3a mutant (TM FOXO3a) (Brunet et al., 1999) and WT FOXO3a were equally cleaved by caspase-3 and -7 and staurosporinestimulated Jurkat cells extracts, suggesting that mutation of FOXO3a at these sites does not modify caspases accessibility. Our results show that the cleavage of FOXO3a by caspase-3-like enzymes at DELD 304 site leads to the separation of the DBD (40 kDa) from the transactivation domain (TAD) (45 kDa) independently of the presence of Akt phosphorylation sites (Figure 5b ).
Subcellular localization of Nt and Ct fragments of FOXO3a and effect on gene transcription and apoptosis
Previous studies have shown that the subcellular localization of FOXO3a regulates its function. To examine the cellular localization of both Nt and Ct fragments produced by FOXO3a cleavage, 293T cells were transfected with HA-WT or HA-TM FOXO3a, HA-D304A, and the Nt-V5 or Ct-V5 fragments isolated Cleavage of FOXO3a by caspases C Charvet et al from both WT and TM FOXO3a. The expression of the transfected protein was analysed by immunofluorescence and nuclei were revealed by PI staining. TM, TM D304A FOXO3a, and the Nt fragment from TM FOXO3a (A32A253 Nt) were clearly localized within the nucleus (Figure 6a , left and right panels). In contrast, WT, WT D304A, the Nt fragment from WT FOXO3a (T32S253 Nt) and both Ct fragments (S315 Ct and A315 Ct) were present in the cytoplasm (Figure 6a , left and right panels). Recent studies have reported that interaction between 14-3-3 and phosphorylated FOXO3a allows the sequestration of FOXO3a in the cytoplasm (Brunet et al., 1999 . To assess the interaction of 14-3-3 with FOXO3a proteolytic fragments, a glutathione S-transferase (GST)-14-3-3 pulldown assay on lysates from transfected 293 T cells was performed. WT, WT D304A and T32S253 Nt FOXO3a bound 14-3-3t, consistent with their cytoplasmic localization ( Figure 6b ). In contrast, the absence of Akt phosphorylation sites on TM, TM D304A, A32A253 Nt prevented binding to 14-3-3 and allowed nucleic accumulation (Figure 6a ). Finally, Ct fragments, either WT or A315 localized to the cytoplasm (Figure 6a ), although they did not bind 14-3-3 (Figure 6b ). Together, these results are consistent with recent studies (Brunet et al., 1999 and suggest that while the FOXO3a Nt fragment can translocate in the nucleus, depending on its phosphorylated state, the Ct fragment always localized in the cytoplasm. FOXO3a is known to regulate transcriptional activation of target genes during apoptosis (Brunet et al., 1999; Nakamura et al., 2000; Alvarez et al., 2001; Tran et al., 2002) . We therefore questioned the potential role of FOXO3a proteolytic fragments on gene transcription and apoptosis. In order to prevent FOXO3a-mediated apoptosis, we first transfected FADD-negative T cells with HA-TM, HA-TM D304A, A32A253 Nt-V5 FOXO3a, and A315 Ct-V5 FOXO3a along with a luciferase reporter from the FasL promoter containing three Forkhead binding sites (FHRE-Luciferase) (Brunet et al., 1999) . TM D304A FOXO3a was a more potent transcriptional activator than TM FOXO3a (four fold increase against twofold increase over basal activity), suggesting that this mutation could stabilize FOXO3a protein (Figure 6c ). In contrast, A32A253 Nt inhibited the basal FHRE activity, and A315 Ct failed to affect FHRE luciferase activity (Figure 6c ). Next, WT Jurkat cells were transfected with FOXO3a mutants their effects on apoptosis were examined. TM D304A FOXO3a was a more potent inducer of apoptosis than TM FOXO3a, correlating with its effect on FHREdependent transcription (Figure 6c ). Interestingly, both fragments were inactive in inducing apoptosis (Figure 6c ). These results indicate that while a cleavage-resistant form of FOXO3a increases target gene transcription and apoptosis, cleavage of FOXO3a prevents its proapoptotic function in lymphoid cells.
Discussion
The Forkhead family of transcription factors are important regulators of cell cycle progression in a large variety of cells and apoptosis in hematopoietic cells. Immunostaining of transiently transfected 293T cells with HA-WT, HA-TM FOXO3a, HA-D304A, and Nt-V5 or Ct-V5 fragments from WT (T32S253 Nt and S315 Ct) and TM FOXO3a (A32A253 Nt and A315 Ct) (10 mg) and the empty vectors (left panels) and corresponding PI staining (medium panels). Merge is shown (right panels). (b) 293 T cells were transfected with WT, TM FOXO3a, D304A, and Nt and Ct fragments from WT or TM FOXO3a (10 mg) and empty vectors. After 24 h, lysates were incubated with GST-14-3-3t and complexes formed were analysed by Western blotting with antibodies against HA, V5, or GST to detect WT and TM FOXO3a, Nt and Ct fragments, and GST-14-3-3t, respectively. As a control, whole lysates were analysed with same antibodies. (c) (Upper panel) FADD-negative cells were cotransfected with empty vector, HA-tagged TM, TM D304A FOXO3a, A32A253 Nt, or A315 Ct (10 mg) along with FHRE luciferase reporter (2 mg) and cultured for 24 h. Cells were then lysed for luciferase assay. Here, we have examined the fate of FOXO3a (also known as FKHRL1), a member of the Forkhead family, during Fas-induced apoptosis in lymphocytes. We found that in CD4 þ peripheral T cells subjected to AICD and in leukemic Jurkat cells stimulated by anti-Fas antibody, FOXO3a was cleaved by caspase-3-like proteases early after Fas engagement. FOXO3a cleavage released two inactive fragments, while expression of a cleavageresistant form of FOXO3a increased FHRE-dependent transcription and apoptosis. Two major pathways for caspases activation have been characterized: an 'extrinsic' pathway initiated by death receptors-induced assembly of DISCs resulting in the activation of procaspase-8 and an 'intrinsic' pathway triggered by mitochondrial dysfunction, cytochrome release, and procaspase-9 activation (Krammer, 2000) . Both pathways then activate similar downstream effector caspases including caspase-3, -6, and -7 that cleave critical cellular proteins. The observation that FADD-negative and procaspase-8-negative leukemic T cells, which are unable to execute the Fas-mediated apoptotic program, were also unable to promote FOXO3a cleavage, indicates that a Fas-dependent extrinsic pathway is responsible for FOXO3a cleavage in lymphocyte. Also, under our conditions (i.e. low doses of Fas antibody), FOXO3a's cleavage could be detected as soon as 1 h following Fas treatment, well before mitochondrial dysfunction and cytochrome c release. Moreover, overexpression of FLIP-L, which blocks the recruitment of procaspase-8 to the DISC (Irmler et al., 1997) , and treatment with PMA, a blocker of DISC assembly (Gomez-Angelats and Cidlowski, 2001), prevented FOXO3a cleavage, highlighting the importance of the Fas-associated death pathway for FOXO3a proteolysis (Figure 7 ).
Several observations argue for a role of caspase-3-like activity in apoptosis-related FOXO3a proteolysis. This cleavage correlated with caspase-mediated PARP proteolysis in apoptotic leukemic cells as well as in peripheral CD4 þ T cells undergoing AICD, whereas other proteins such as actin were not cleaved during the time frame of Fas stimulation in these experiments. Moreover, Fas-induced proteolysis of FOXO3a could be prevented in vivo by the broad-spectrum caspase inhibitor Z-VAD-Fmk and the caspase-3 specific inhibitor Ac-DEVD-CHO. Further evidence consistent with a cleavage of FOXO3a by a downstream effector caspase comes from our observation that the cleavage occurs at a consensus site for caspase-3-like enzymes, DELD 304 , localized between the DBD and the TAD. The optimal recognition motif sequence for group II caspases, which includes caspase-3 and -7, has been determined to be DEXD (Grutter, 2000) , similar to the FOXO3a cleavage sequence. Interestingly, in vitro cleavage by recombinant caspase-3 and -7, or cellular lysates from staurosporine-stimulated Jurkat cells, generated similar fragments, while cleavage by caspase-6 seemed to be different, suggesting that additional cleavage sites may exist in FOXO3a sequence. Consistently, the sequence specificity of caspase-6, which was determined to be (I/V/L)EXD (Grutter, 2000) , appears to be different from the FOXO3a cleavage sequence. Moreover, replacement of the aspartate residue in position 304 to alanine (Asp 304 to Ala 304 mutation) was sufficient to fully protect FOXO3a from caspasedependent cleavage, demonstrating that this site is predominantly targeted by caspase-3-like enzyme during Fas-induced apoptosis. Our observation that FOXO3a is not cleaved in MCF-7 breast cancer cells (data not shown), which are deficient in caspase-3 activity (Talanian et al., 1997) , further supports the notion that Figure 7 Model of caspase-dependent FOXO3a's cleavage. During apoptosis, Fas engagement with FasL leads to DISC assembly and induces the activation of the caspase-3 family. The caspase-3 family cleaves FOXO3a at the identified consensus site DELD 304 to generate a N-terminal fragment containing the DBD and both nuclear localization sites (NLS) (aas 1-304), and a Cterminal fragment containing the TAD and both nuclear exclusion sites (NES) (aas 305-674). When phosphorylated, the Nt fragment conserves its association with 14-3-3 and is retained in the cytoplasm. The Ct fragment is also localized in the cytoplasm but does not bind 14-3-3. When dephosphorylated, the Nt fragment translocates into the nucleus, leading to the inhibition of target gene transcription. In contrast, the Ct fragment does not translocate in the nucleus, and is inactive on gene transcription Cleavage of FOXO3a by caspases C Charvet et al caspase-3 is directly responsible for FOXO3a proteolysis. Together, these results indicate that caspase-3-like proteases mediate FOXO3a cleavage in apoptotic lymphocytes.
We found in this study that FOXO3a proteolysis occurs just after the DBD, therefore generating two fragments: an amino-terminal (Nt) fragment at 40 kDa containing the DBD, and a carboxyterminal (Ct) fragment at 45 kDa with the TAD (Figure 7) . FOXO3a is known to transit from the cytoplasm to the nucleus depending on its activation state, a process mainly regulated by Akt-mediated phosphorylation of critical serine and threonine residues (Brunet et al., 1999) . Recent papers showed that phosphorylated FOXO3a is sequestered in the cytoplasm by associating with the chaperon protein 14-3-3, while dephosphorylated FOXO3a shuttles into the nucleus without binding 14-3-3, resulting in transcriptional activity of target genes (Brunet et al., 1999 . These results led us to examine the subcellular localization and binding to 14-3-3 of FOXO3a fragments. We showed that Ct fragments, lacking 14-3-3 binding sites always localized into the cytoplasm irrespective to their phosphorylated state. However, the phosphorylable Nt fragment was cytoplasmic and associated with 14-3-3, whereas the dephosphorylable Nt fragment was nuclear, and unable to bind 14-3-3, suggesting that only this fragment conserved the same mechanism of nucleocytoplasmic transport as fulllength FOXO3a. Unphosphorylated FOXO3a fragments could naturally be produced in apoptotic cells as a consequence of the caspase-dependent cleavage of Akt (Widmann et al., 1998) . Following Akt inactivation in apoptotic cells, FOXO3a fragments would no longer be phosphorylated, therefore becoming biologically active.
Caspase-mediated proteolysis of specific cellular protein is a common feature of apoptosis (Widmann et al., 1998) . In some cases, proteolysis is instrumental of cell death through the generation of active protein fragments. Cleavage of transcription factors, such as SRF (Bertolotto et al., 2000; Drewett et al., 2001) , and NF-kB (Ravi et al., 1998) , has been observed in apoptotic cells, usually resulting in a decreased transcriptional activity. Recent studies have shown that FOXO3a regulates apoptosis and cell cycle in hematopoietic cells through the transcription of target genes, such as FasL (Brunet et al., 1999) , Bim (Dijkers et al., 2000a) , and p27kip1 (Dijkers et al., 2000b) , whose promoters contain FHREs. Thus, one important issue is to determine the exact role of the proteolytic cleavage of FOXO3a during apoptosis. We found that whereas fulllength constitutive active FOXO3a-enhanced FHREdependent transcription, unphosphorylable FOXO3a fragments were transcriptionally inactive or even slightly dominant negative in the case of the unphosphorylable Nt fragment. Also, we found that forced expression of a constitutively active FOXO3a in leukemic cells rapidly induced cell death, consistent with previous studies (Brunet et al., 1999; Dijkers et al., 2000a) . In contrast, expression of either Nt or Ct FOXO3a fragments was totally inactive to promote cell death. The observation that a caspase-resistant mutant of FOXO3a TM exhibited an increased transcriptional and proapoptotic activity further supports the notion that FOXO3a proteolysis may be an important regulatory step during apoptosis. Interestingly, a recent study has shown that fragments of a FOXO3a target, p27kip1, generated following effector caspases activation, could delay etoposide-induced cell death, whereas caspase-resistant p27kip1 increased etoposide-induced cell death (Eymin et al., 1999) . Although it is not known whether p27kip1 cleavage could also regulate death receptors-mediated cell death, it is tempting to propose that the Fasmediated cleavage of FOXO3a and one of its target, p27kip1, would similarly affect cell cycle and/or apoptosis in hematopoietic cells. Also, it would be interesting to examine whether FOXO3a fragments could similarly regulate DNA damage-induced apoptosis in hematopoietic cells since we observed that etoposide triggered FOXO3a proteolysis. Together, our results suggest that caspase-mediated cleavage of FOXO3a negatively regulates the proapoptotic pathways controlled by FOXO3a in lymphoid cells. This process would provide mechanisms for the cell to survive and repair damages induced by apoptotic stimuli, in a situation where caspases activation does not lead to irremediable apoptosis.
Two closely related mammalian members of the FOXO family, FOXO4 (AFX) and FOXO1a (FKHR), also contain a conserved caspase cleavage site in a similar position. Although the cleavage of FOXO4 and FOXO1a following death receptors engagement were not addressed in this study, the presence of such a conserved motif in all three proteins sequence suggests a general role of caspases in the regulation of the FOXO family function. Further investigation will be required to clarify the role of FOXO3a cleavage in cellular processes, such as cell differentiation and cell death, where caspases activity appears to be crucial.
Materials and methods
Antibodies and reagents
Anti-CD3 (OKT3) and anti-CD99 mAbs were purified from hybridoma supernatants. Anti-HA mAb (12CA5) was from Roche (Meylan, France). Anti-FOXO3a, anti-Akt, anti-PARP, and anti-GST antibodies were from Santa Cruz Biotechnology, Inc (Santa Cruz, CA, USA). Antiphosphothreonine 32 FOXO3a, anti-Fas (CH11) and anti-Flag M2 antibodies were from Upstate Biotechnology, Inc. (Lake Placid, NY, USA). Anti-V5 antibody was from Invitrogen (Groningen, Netherlands). Antiactin antibody was from Chemicon International (Temecula, CA, USA). Anticaspase-3 was from Transduction Laboratory. FITCcoupled rabbit anti-mouse antibody was from Dako (Carpentia, IL, USA). Z-VAD-Fmk was from Bachem (Philadelphia, USA). Ac-DEVD-CHO and Ac-YVAD-CHO were from Calbiochem (Darmstadt, Germany). Recombinant human IL-2 was from R&D system (Minneapolis, MN, USA). Nocodazole, etoposide, and staurosporine were from Sigma (St Louis, MO, USA).
Cell culture and transfection CD4 þ T lymphocytes were obtained as described elsewhere (Noraz et al., 2000) . Cells were cultured in Yssel medium supplemented with 1% human AB þ serum and recombinant human IL-2 (100 U/ml). Cells were stimulated weakly with phytohemagglutinin (5 mg/ml) (Murex, Dartford, England) and with irradiated feeders cells consisting of peripheral blood mononuclear cells and the Epstein-Barr virus-transformed Bcell line JY. Jurkat T cells clones (parental A3, FADD negative and caspase-8 (FLICE) negative) were gifts from J Blenis (Juo et al., 1998 . The Jurkat clone Jr was described previously (Ricci et al., 2001) . Cells were grown in RPMI 1640 medium, supplemented with 10% fetal bovine serum (FBS), 2 mm glutamine, 1 mm sodium pyruvate, 10 mm HEPES, 1 Â MEM nonessential amino acids solution and 100 U/ml of each penicillin G and streptomycin. Cells in a logarithmic growth phase were transfected with the indicated plasmids by electroporation as described previously (Charvet et al., 2002) .
Plasmid constructs
The cDNA encoding HA-tagged WT and TM FOXO3a were subcloned from pECE constructs (Brunet et al., 1999) into pCDNA3 using HindIII/XbaI digestion. Nt and Ct fragments were amplified from pCDNA3 HA-FOXO3a WT or TM by PCR using the following primers: 5 0 FOXO3a-Nt: 5 0 -AC-CATGGCAGAGGCACCG-3 0 and 3 0 FOXO3a-Nt: 5 0 -CAG CTCATCACTGCTGCGTGACGTGGG-3 0 , 5 0 FOXO3a-Ct: 5 0 -ACCATGGCGTGG ACGGACTTCCG TTCA-3 0 and 3 0 FOXO3a-Ct: 5 0 -GCCTGGCACCCAGCTC TG-3 0 . The amplified fragments were directly ligated into the V5-tagged pCDNA3.1 vector (Invitrogen, Groningen, Netherlands). FHRE-Luciferase reporter was a gift from M Greenberg (Brunet et al., 1999) . Flag-tagged FLIP-L was a gift from J Tschopp (Irmler et al., 1997) . The vector encoding GST-14-3-3t was provided by Y-C Liu (San Diego, CA, USA). Asp 304 was mutated to alanine using the primer 5 0 -AGCAGTGAT-GAGCTGGCTGCGTGGACGGACTTC-3 0 and complementary oligonucleotide by overlap extension using the QuickChange mutagenesis kit (Stratagene, CA, USA). The mutation was confirmed by sequencing.
Caspase activity measurement
Each assay (in triplicate) was performed with 100 mg of protein prepared from control cells or cells stimulated for differebt times with 100 ng/ml CH11. Briefly, cellular extracts were then incubated in a 96-well plate, with 0.2 mm of Ac-DEVD-pNA as substrates for various times at 371C as previously described (Herrant et al., 2002) . Caspase activity was measured at 410 nm in the presence or absence of 1 mm of Ac-DEVD-CHO or Ac-LEHD-CHO or Ac-IETD-CHO. The specific caspase activity was expressed in nmoles of paranitroaniline released per min and per mg of protein.
GST pull-down assay and immunoblotting GST-14-3-3t fusion proteins were produced as described before (Deckert et al., 1996) . For GST pull-down analysis, cells were washed twice in phosphate-buffered saline (PBS) and lysed at 1 Â 10 8 cells/ml in ice-cold lysis buffer (1% Triton -X-100 in 150 mm NaCl, 50 mm HEPES pH 7.4, 5 mm NaF, 5 mm sodium pyrophosphate, 1 mm sodium orthovanadate, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mm PMSF) for 15 min on ice. After centrifugation, cell lysates were incubated with 5 mg of GST-14-3-3t for 3 h at 41C, followed by incubation with glutathione-sepharose 4B beads (Pharmacia) for 1 h. Samples were washed three times in lysis buffer. Precipitates or samples from whole-cell lysates were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and analysed by immunoblotting. Reactive proteins were visualized by enhanced chemiluminescence. In vitro transcription/translation assay WT, TM, and D304A FOXO3a from pCDNA3 FOXO3a were transcribed and translated using the TNT-coupled reticulocyte lysate system (Promega, Madison, WI, USA) in the presence of [ 35 S]methionine. In vitro translated FOXO3a (2.5 ml) was incubated in 50 ml of 25 mm HEPES pH 7.5, 0.1% CHAPS, 2 mm DTT with 100 ng of recombinant caspase-3, -6, -7, or 150 mg of staurosporine-stimulated Jurkat T cells either in the presence or absence of 10 mm Ac-DEVD-CHO for 16 h at 371C. Reactions were separated on a 8% SDS-PAGE and analysed by autoradiography.
Immunolocalization
293T cells were grown in DMEM/10% FBS to approximately 70% confluence on glass coverslips in six-well plates, and transfected with 2.5 mg of different FOXO3a constructs using effectene transfection reagent (Qiagen, Valencia, CA, USA). After 24 h, cells were fixed with 4% paraformaldehyde in buffer A (PBS, 0.1% BSA, 1 mm MgCl 2 , 1 mm CaCl 2 ) for 15 min at 371C. Fixation was then stopped with buffer A/ 50 mm NH 4 Cl for 15 min at 371C, and permeabilized in buffer A/0.05% saponin for 20 min at 371C. Coverslips were incubated with anti-HA or anti-V5 antibodies in buffer A for 30 min at 371C. After three washes with buffer A, samples were incubated with FITC-coupled rabbit anti-mouse antibodies for 45 min at 371C. For detection of nuclei, cells were incubated with 20 ng/ml PI (Sigma, St Louis, MO, USA) for 5 min at room temperature and washed three times with buffer A. Coverslips were mounted on glass slides with antibleaching reagent (Calbiochem, San Diego, CA, USA) and examined by laser scanning confocal microscopy.
Abbreviations AICD, activation-induced cell death; DISC, death-inducing signaling complex; FLIP-L, FLICE-inhibitory protein; GFP, green fluorescent protein; GST, glutathione S-transferase; IL-2, interleukin-2; NES, nuclear export signal; NLS, nuclear localization signal; PARP, poly(ADP-ribose) polymerase; PI, propidium iodide; PMA, phorbol myristate acetate; TCR, Tcell receptor; TM, triple mutant; WT, wild type.
